相关实验视频

Updated: Sep 20, 2025

Modeling Neural Immune Signaling of Episodic and Chronic Migraine Using Spreading Depression In Vitro

Modeling Neural Immune Signaling of Episodic and Chronic Migraine Using Spreading Depression In Vitro

Published on: June 13, 2011

在慢性偏头痛模型中,TLR3通过ERK信号通路通过重复的酸甘诱导的中心敏感化

Bin Yang¹, Zhaoming Ge²

¹Department of Neurology, Lanzhou University Second Hospital, Lanzhou, Gansu, China.

|May 23, 2025

概括

收费类受体3 (TLR3) 与慢性偏头痛 (CM) 中央敏感性有关. 抑制TLR3,TRAF6,TAK1或ERK信号传递可以缓解小鼠的CM类行为和过敏症.

科学领域:

神经科学是一个神经科学.
免疫学免疫学免疫学
疼痛研究疼痛研究

背景情况:

已知托尔类受体3 (TLR3) 参与神经病痛.
对于TLR3在偏头痛慢性化中的作用仍然基本上未被探索.
这项研究研究了TLR3在与慢性偏头痛 (CM) 相关的中央敏感化中的分子机制.

研究的目的:

阐明TLR3在慢性偏头痛 (CM) 中央敏感化中的作用.
探索涉及TLR3介导CM的分子通路,包括TRAF6-TAK1轴和ERK信号传输.
评估向TLR3和CM相关途径的治疗潜力.

主要方法:

已建立的慢性偏头痛 (CM) 鼠标模型使用酸甘 (NTG) 注射.
在后腿和周围轨道区域通过·弗雷丝 filaments 评估机械体.
利用西方斑点和免疫光学来分析蛋白质表达 (TLR3,TRAF6,TAK1,c-Fos,CGRP,ERK) 和三胞胎尾骨核 (TNC) 中的通路激活.
研究了特定抑制剂 (TLR3,MEK,TRAF6,TAK1) 对CM行为和中央敏感性标记物的影响.

主要成果:

反复的NTG给药显著提高了TLR3,TRAF6,TAK1,c-Fos,CGRP的调节,并激活了CM小鼠的ERK信号通路.
抑制TLR3,TRAF6,TAK1或ERK信号通路可以逆转这些分子变化.
这些途径的药理阻塞在小鼠模型中有效缓解过敏症和CM类行为.

结论:

在慢性偏头痛 (CM) 背后的中央敏感化中,TLR3发挥着重要作用.
TRAF6-TAK1轴调节ERK信号通路,调节TLR3在CM中的影响.
针对TLR3及其下游信号通路,为治疗慢性偏头痛提供了一个潜在的治疗策略.

关键词:

埃尔克·埃尔克是什么意思在TLR3中,它是TLR3.中央敏感化中心慢性偏头痛慢性偏头痛慢性偏头痛神经元神经元的神经元

更多相关视频

Ex Vivo Release of Calcitonin Gene-Related Peptide from the Trigeminovascular System in Rodents

Ex Vivo Release of Calcitonin Gene-Related Peptide from the Trigeminovascular System in Rodents

Published on: May 16, 2022

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

相关概念视频

Nitric Oxide Signaling Pathway

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...

MAPK Signaling Cascades

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...

Enzyme-linked Receptors

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...